What Is End-of-Life Care Like for Congestive Heart Failure?
By CRYSTAL BAI •
The short answer: End-of-life care for advanced congestive heart failure (CHF) focuses on managing breathlessness, fluid accumulation, fatigue, and anxiety — primarily through diuretics, opioids for breathlessness, and anxiolytics. Like COPD, CHF has an unpredictable trajectory with sudden deterioration, making early advance care planning essential.
End-of-Life Care for Congestive Heart Failure (CHF)
Congestive heart failure (CHF) — also called heart failure — is a chronic condition in which the heart cannot pump blood effectively, leading to fluid buildup in the lungs and body. It affects approximately 6 million Americans and is one of the most common causes of hospitalization and death in older adults. Advanced CHF carries a prognosis similar to many cancers, yet patients receive far less palliative care and hospice support.
The CHF Disease Trajectory
Heart failure is classified by severity using the New York Heart Association (NYHA) classes:
- Class I: No symptoms with ordinary activity
- Class II: Slight limitation, symptoms with moderate exertion
- Class III: Marked limitation, symptoms with minimal activity
- Class IV: Symptoms at rest, inability to perform any activity without discomfort
End-of-life care is most relevant for NYHA Class III–IV patients. Unlike cancer, CHF has an unpredictable trajectory — patients may have periods of stability punctuated by sudden acute decompensation. Death may come suddenly (cardiac arrest) or gradually through progressive organ failure.
Common Symptoms at End of Life in CHF
- Dyspnea (breathlessness): The most distressing symptom — can range from exertion-related to severe breathlessness at rest
- Orthopnea: Inability to lie flat due to breathlessness — many patients sleep propped up
- Edema (fluid buildup): Swelling in legs, ankles, abdomen (ascites) from fluid accumulation
- Extreme fatigue: Even minimal activity is exhausting
- Cardiac cachexia: Progressive weight loss and muscle wasting in advanced CHF
- Cognitive impairment: Reduced cardiac output affects brain function
- Anxiety and depression: Extremely common — breathlessness creates profound anxiety
- Renal failure: CHF often leads to cardiorenal syndrome with kidney dysfunction
Comfort-Focused Management at End of Life
Diuretics: Continue to relieve fluid buildup and breathlessness. IV diuretics may be given in hospice settings for refractory fluid overload.
Opioids: Low-dose opioids (morphine) are the most effective treatment for breathlessness at end of life in CHF — similar to COPD. They reduce the sensation of air hunger significantly.
Anxiolytics: Lorazepam or other agents to address the anxiety and panic component of breathlessness.
Positioning: Upright positioning (head-of-bed elevated, recliner chairs) reduces orthopnea.
Deactivating ICDs: Implantable cardioverter-defibrillators (ICDs) should be deactivated as part of end-of-life planning — if the heart enters a fatal rhythm, the ICD will deliver painful shocks that provide no benefit in end-stage disease. This is a critical conversation that many clinicians avoid.
Transitioning to Hospice with CHF
Many CHF patients are hospitalized repeatedly for acute decompensation and discharged without serious discussion of hospice. Medicare hospice criteria for CHF include: NYHA Class IV symptoms, ejection fraction under 20%, inability to tolerate optimal therapy, and one of several clinical markers. The challenge: prognostication is difficult. Cardiologists should initiate goals-of-care conversations proactively, not only in crisis.
Frequently Asked Questions
What are the end-of-life symptoms of congestive heart failure?
End-of-life symptoms of CHF include severe breathlessness (even at rest), inability to lie flat, severe fluid buildup in the legs and abdomen, profound fatigue, cognitive changes, cardiac cachexia (muscle wasting), and anxiety. Sudden cardiac death (arrhythmia) is also possible at any point in advanced CHF.
Should an ICD be turned off at the end of life?
Yes. An ICD (implantable cardioverter-defibrillator) should typically be deactivated when a CHF patient is in the final stages of life and choosing comfort care. If a fatal arrhythmia occurs, the ICD will deliver multiple painful shocks that provide no benefit in end-stage disease. Deactivation is a standard, ethical part of comfort-focused end-of-life care — not equivalent to stopping life support.
When should CHF patients enroll in hospice?
CHF patients with NYHA Class IV symptoms, ejection fraction under 20%, and inability to tolerate therapy may qualify for hospice. Many CHF patients are readmitted to the hospital repeatedly without receiving hospice — which could provide much better symptom management and quality of life. If you or a loved one has CHF and has been hospitalized 2+ times in the past year, a goals-of-care conversation about hospice is worth having.
Is CHF terminal?
Advanced CHF is a terminal condition with a 5-year survival rate of approximately 50% and 1-year survival for advanced NYHA Class IV of under 50%. Yet CHF often doesn't feel 'terminal' in the same way cancer does — patients have good days and bad days, leading to delayed hospice enrollment. CHF patients deserve the same palliative care attention as cancer patients.
Do opioids help with CHF breathlessness?
Yes. Low-dose opioids (particularly oral or sublingual morphine) are among the most effective treatments for breathlessness in advanced CHF. They reduce the central sensation of air hunger without significantly affecting oxygen levels when used in palliative doses. Hospice teams with experience in cardiac disease manage this effectively.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.